Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer

NCT00677924 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Due to changes in portfolio review

Conditions

Interventions

Sponsor

Genmab